Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

Name: Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)
Published: 2020
License: Public Domain

Incyte Corporation · 2020

ClinicalTrials.gov · Datasets · License: Public Domain · 2020

Open Source ↗

ards pneumonia sars-cov-2

covid-19, cytokine storm, ards, sars-cov-2, ruxolitinib, pneumonia, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)

Related documents